Worth reading
67In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
37600
unitsWording
Conditional
How definitive the wording is.Details of issuance or disposal
Acquisition and cancellation of share acquisition rights with an exercise price adjustment clause
Intended allottee
EVO FUND (37,600 remaining stock acquisition rights)
Amount of funds to be raised
Amount raised to date through the 10th Series Stock Acquisition Rights: ¥546 million; estimated net proceeds: Not disclosed
Specific use of funds
Funds for the acquisition of storage facilities for the grid-scale battery storage businessAmount ¥226 million
Working capitalAmount ¥186 million
Terms of the stock acquisition rights
Exercise price
Initial exercise price: ¥214; minimum exercise price: ¥107. The exercise price is adjusted in line with the share price and had been adjusted to ¥107 as of 16 September 2026.
Number of Stock Acquisition Rights
Total issued: 82,700; unexercised balance: 37,600 (as of 16 September 2026)
Most recent equity financing
Timing 13 February 2026 / Type 10th Series Stock Acquisition Rights (with provisions for adjustment of the exercise price) and 11th Series Stock Acquisition Rights issued through a third-party allotment / Amount Initially projected amount to be raised through the 10th Series Stock Acquisition Rights: ¥1,769 million; amount raised to date: ¥546 million
Impact on Business Performance
The impact on consolidated results for the fiscal year ending December 2026 is expected to be immaterial.
| Item | Details |
|---|---|
| Type of issuance or disposal | Acquisition and cancellation of share acquisition rights with an exercise price adjustment clause |
| Amount of funds to be raised | Amount raised to date through the 10th Series Stock Acquisition Rights: ¥546 million; estimated net proceeds: Not disclosed |
| Specific use of funds | Details Funds for the acquisition of storage facilities for the grid-scale battery storage business / Amount ¥226 million / Scheduled timing of expenditures Not disclosed, Details Working capital / Amount ¥186 million / Scheduled timing of expenditures Not disclosed |
| Intended allottee | EVO FUND (37,600 remaining stock acquisition rights) |
| Exercise price | Initial exercise price: ¥214; minimum exercise price: ¥107. The exercise price is adjusted in line with the share price and had been adjusted to ¥107 as of 16 September 2026. |
| Number of Stock Acquisition Rights | Total issued: 82,700; unexercised balance: 37,600 (as of 16 September 2026) |
| Most recent equity financing | Timing 13 February 2026 / Type 10th Series Stock Acquisition Rights (with provisions for adjustment of the exercise price) and 11th Series Stock Acquisition Rights issued through a third-party allotment / Amount Initially projected amount to be raised through the 10th Series Stock Acquisition Rights: ¥1,769 million; amount raised to date: ¥546 million |
| Impact on Business Performance | The impact on consolidated results for the fiscal year ending December 2026 is expected to be immaterial. |
Items this document does not state (20)
Number of shares to be issued or disposed ofIssue price and disposal priceTotal issue valueEstimated issuance expensesPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offering
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company determined that, although the current share price is below the minimum exercise price and recent exercises have been limited, the importance of promptly eliminating concerns about future dilution from the remaining stock acquisition rights and their impact on the supply and demand of the shares outweighed the fundraising benefits.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.